We review currently available computational tools which can be used to assess and report novel gene variants, focusing on their application and utility for the analysis of SERPINA1 and its product AAT protein, which are associated with the etiology of AATD. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.